BEXLAMDA Trademark

Trademark Overview

On Thursday, June 15, 2017, a trademark application was filed for BEXLAMDA with the United States Patent and Trademark Office. The USPTO has given the BEXLAMDA trademark a serial number of 87491256. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 12, 2021. This trademark is owned by Bristol-Myers Squibb Company. The BEXLAMDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer
bexlamda

General Information

Serial Number87491256
Word MarkBEXLAMDA
Filing DateThursday, June 15, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 12, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 10, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 22, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, July 12, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 12, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 4, 2021EXTENSION 5 GRANTED
Monday, December 7, 2020EXTENSION 5 FILED
Monday, December 21, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 7, 2020TEAS EXTENSION RECEIVED
Tuesday, June 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 5, 2020EXTENSION 4 GRANTED
Friday, June 5, 2020EXTENSION 4 FILED
Friday, June 5, 2020TEAS EXTENSION RECEIVED
Friday, December 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 4, 2019EXTENSION 3 GRANTED
Wednesday, December 4, 2019EXTENSION 3 FILED
Wednesday, December 4, 2019TEAS EXTENSION RECEIVED
Friday, June 7, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 5, 2019EXTENSION 2 GRANTED
Wednesday, June 5, 2019EXTENSION 2 FILED
Wednesday, June 5, 2019TEAS EXTENSION RECEIVED
Friday, December 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 5, 2018EXTENSION 1 GRANTED
Wednesday, December 5, 2018EXTENSION 1 FILED
Wednesday, December 5, 2018TEAS EXTENSION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 21, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 21, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 5, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 10, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 10, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 21, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 8, 2018ASSIGNED TO LIE
Friday, March 2, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 27, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 26, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 26, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 25, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 25, 2017NON-FINAL ACTION E-MAILED
Friday, August 25, 2017NON-FINAL ACTION WRITTEN
Friday, August 18, 2017ASSIGNED TO EXAMINER
Thursday, June 22, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 19, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

bexlamda diseases pharmaceutical disorders cancer anti human preparations treatment transplant rejection